Читать книгу Vitamin D in Clinical Medicine - Группа авторов - Страница 51

1Cooke NE, Haddad JG: Vitamin D binding protein (Gc-globulin). Endocr Rev 1989;10:294–307.

2Speeckaert M, Huang G, Delanghe JR, Taes YE: Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006;372:33–42.

3Benis KA, Schneider GB: The effects of vitamin D binding protein-macrophage activating factor and colony-stimulating factor-1 on hematopoietic cells in normal and osteopetrotic rats. Blood 1996;88:2898–2905.

4Schneider GB, Benis KA, Flay NW, Ireland RA, Popoff SN: Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 1995;16:657–662.

5Hollis BW, Bikle DD: Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med 2014;370:879–880.

6Nykjaer A, Fyfe JC, Kozyraki R, Leheste JR, Jacobsen C, Nielsen MS, et al: Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci USA 2001;98:13895–13900.

7Daiger SP, Schanfield MS, Cavalli-Sforza LL: Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci USA 1975;72:2076–2080.

8Gibbs PE, Dugaiczyk A: Origin of structural domains of the serum-albumin gene family and a predicted structure of the gene for vitamin D-binding protein. Mol Biol Evol 1987;4:364–379.

9Cooke NE, Willard HF, David EV, George DL: Direct regional assignment of the gene for vitamin D binding protein (Gc-globulin) to human chromosome 4q11-q13 and identification of an associated DNA polymorphism. Hum Genet 1986;73:225–229.

10Svasti J, Kurosky A, Bennett A, Bowman BH: Molecular basis for the three major forms of human serum vitamin D binding protein (group-specific component). Biochemistry 1979;18:1611–1617.

11Fu L, Borges CR, Rehder DS, Wong BY, Williams R, Carpenter TO, et al: Characterization of additional vitamin D binding protein variants. J Steroid Biochem Mol Biol 2016;159:54–59.

12White P, Cooke N: The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000;11:320–327.

13Gomme PT, Bertolini J: Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 2004;22:340–345.

14McLeod JF, Cooke NE: The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues. J Biol Chem 1989;264:21760–21769.

15Cooke NE, McLeod JF, Wang XK, Ray K: Vitamin D binding protein: genomic structure, functional domains, and mRNA expression in tissues. J Steroid Biochem Mol Biol 1991;40:787–793.

16Bhan I: Vitamin d binding protein and bone health. Int J Endocrinol 2014;2014:561214.

17Chun RF: New perspectives on the vitamin D binding protein. Cell Biochem Funct 2012;30:445–456.

18Delanghe JR, Speeckaert R, Speeckaert MM: Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab 2015;29:773–786.

19Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, et al: Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999;103:239–251.

20Yamamoto N, Homma S: Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA 1991;88:8539–8543.

21Lauridsen AL, Vestergaard P, Nexo E: Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 2001;47:753–756.

22Henderson CM, Lutsey PL, Misialek JR, Laha TJ, Selvin E, Eckfeldt JH, et al: Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D-binding protein in blacks and whites. Clin Chem 2016;62:179–187.

23Bolland MJ, Grey AB, Ames RW, Horne AM, Mason BH, Wattie DJ, et al: Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin Endocrinol (Oxf) 2007;67:259–264.

24Sollid ST, Hutchinson MY, Berg V, Fuskevag OM, Figenschau Y, Thorsby PM, et al: Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Eur J Endocrinol 2016;174:445–452.

25Pop LC, Shapses SA, Chang B, Sun W, Wang X: Vitamin D-binding protein in healthy pre- and postmenopausal women: relationship with estradiol concentrations. Endocr Pract 2015;21:936–942.

26Moller UK, Streym S, Jensen LT, Mosekilde L, Schoenmakers I, Nigdikar S, et al: Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients 2013;5:3470–3480.

27Bikle DD, Gee E, Halloran B, Haddad JG: Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984;74:1966–1971.

28Shoukry A, Bdeer Sel A, El-Sokkary RH: Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Mol Cell Biochem 2015;408:25–35.

29Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, et al: Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009;7:28.

30Ghafouri B, Carlsson A, Holmberg S, Thelin A, Tagesson C: Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study. BMC Musculoskelet Disord 2016;17:206.

31Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53–58.

32Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–1930.

33Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M: Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 2014;144(Pt A):132–137.

34Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, et al: An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999;96:507–515.

35Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW: Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008;149:3656–3667.

36Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al: Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991–2000.

37Santos BR, Mascarenhas LP, Boguszewski MC, Spritzer PM: Variations in the vitamin D-binding protein (DBP) gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study. Horm Res Paediatr 2013;79:162–168.

38Nielson CM, Jones KS, Chun RF, Jacobs JM, Wang Y, Hewison M, et al: Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racialgenotypic associations. J Clin Endocrinol Metab 2016;101:2226–2234.

39Li C, Chen P, Duan X, Wang J, Shu B, Li X, et al: Bioavailable 25(OH)D but not total 25(OH)D is an independent determinant for bone mineral density in Chinese postmenopausal women. EBioMedicine 2017;15:184–192.

40Lauridsen AL, Vestergaard P, Hermann AP, Moller HJ, Mosekilde L, Nexo E: Female premenopausal fracture risk is associated with gc phenotype. J Bone Miner Res 2004;19:875–881.

Marise Lazaretti-Castro, MD, PhD

Universidade Federal de São Paulo

Rua Botucatu 806, Vila Clementino

São Paulo, SP 04023–062 (Brazil)

E-Mail marise.lazaretti@imabrasil.com.br